PIK3C2A and neuroleptic malignant syndrome: The clinical manifestations of NMS include hyperthermia, rigidity, tremor, autonomic instability, diaphoresis, dysphagia, altered mental status, leukocytosis, and elevated creatine phosphokinase (CPK) levels [2].